Office Based Treatment of Opioid Dependence

Summary and Accreditation Information

8-Hour MAT Waiver Training

This CME activity is a dynamic, web-based, computer-guided experience that allows learners to participate in the training “on their own time” to receive CME Credit and a Buprenorphine Training Certificate.

Release Date: January 23, 2015 Expiration Date: January 23, 2018

CME Accreditation

American Academy of Addiction Psychiatry is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

American Academy of Addiction Psychiatry designates this enduring material for a maximum of 8 AMA PRA Category 1 Credits™. Providers should claim only the credit commensurate with the extent of their participation in the activity.

Method of provider participation in the learning process

A few minutes after you purchase the course, you should see the email in your Inbox. If you do not, please check your email program's Junk or Spam folder.

The estimated time to complete all modules in this activity is 8 hours. To receive 8 AMA PRA Category 1 Credits™ and a Buprenorphine Training Completion Certificate you must:

  1. Register, access and complete the 8-module training provided in this activity.

  2. Receive a minimum cumulative score of 75% on the examination.

  3. Complete the post-training evaluation survey.

Once you sign up and submit your payment for this training, you must complete the course within 45 days of registering. No refunds will be issued.

Target Audience

This program is designed for providers who are likely to treat patients with opioid use disorders in their practice, such as those in family practice, general internal medicine, psychiatry, pediatrics, and adolescent medicine specialists. This online training is especially valuable for:

  • Physicians and other primary care providers who are not addiction specialists and who would like to provide treatment for patients with opioid use disorder

  • Addiction specialists who provide treatment for opioid use disorder and who want to increase treatment options.

  • Addiction specialists who have not treated opioid use disorder in their practices, but who want to learn how to do so.

  • Addiction specialists who want to supplement face-to-face training, refresh their memory, review specific areas, or to review the elements involved in implementing medication assisted treatment (MAT) in the context of office-based treatment.

At the conclusion of this course, participants should be able to:

  • Identify the clinically relevant pharmacological characteristics of buprenorphine/methadone/naltrexone/XR naltrexone.

  • Describe the resources needed to establish office-based treatment with buprenorphine and other medications for patients with opioid use disorders.

  • Distinguish between spontaneous and precipitated opioid withdrawal.

  • Describe the functions of full opioid agonists, partial agonists, and antagonists.

  • Describe several symptoms of opioid withdrawal or intoxication that mimic symptoms of a psychiatric disorder.

  • List the criteria for establishing the diagnosis of opioid use disorder.

  • Describe a number of important factors to consider in determining whether a patient is an appropriate candidate for office-based buprenorphine treatment and MAT.

  • List special treatment considerations associated with adolescents with opioid use disorder.

  • List special treatment considerations associated with adolescents with opioid use disorder.

  • Obtain an understanding of the potential for drug interactions when patients with opioid use disorder are treated for HIV disease or other comorbid disorders requiring medication treatment.

  • Describe the essential areas that should be covered in the rules and expectations communicated to patients during the patient assessment process.

  • Describe elements that must be part of the system for urine testing for the procedures to be clinically valid.

  • List several situations in which patient information, with patient identity, can be shared under current laws protecting a patient's confidentiality.

The system requirements for participation include:

For PC-based participants:

Internet Explorer® 6.0 or newer, Mozilla® Firefox® 3.0 or newer (JavaScriptTM and JavaTM enabled)

Windows® 2000, XP, 2003 Server, Vista or Windows® 7

Cable modem, DSL, or better Internet connection

Minimum of Pentium® class 1GHz CPU with 512 MB of RAM (recommended) (2 GB of RAM for Windows® Vista)

For Mac®-based participants:

SafariTM 3.0 or newer, Firefox® 3.0 or newer (JavaScriptTM and JavaTM enabled)

Mac OS® X 10.4 or newer – Tiger®, Leopard® and Snow Leopard®

PowerPC G4/G5 or Intel processor (512 MB of RAM or better recommended)

Cable modem, DSL, or better Internet connection

Copyright ©2014 American Academy of Addiction Psychiatry - All Rights Reserved

Cost to Purchase the Course

The cost to purchase the course is
$124 AAAP Members
$196 Non-Members

Want to become an AAAP member? Learn more about Member benefits and ways you can save!

Outlook Outlook
iCal iCal
Google Google
Yahoo! Yahoo!